جست‌وجوی استاد و پژوهشگر

Meredith Christine Schumanمشاهده پروفایل

استادیار

• Molecular Ecology
• Chemical Ecology
• Plant–Herbivore–Microbe Interactions
• +۷ مورد دیگر

Meredith Christine Schuman is an Assistant Professor at the University of Zurich (UZH), with dual affiliations in the Department of Geography and the Department of Chemistry. She previously held positions as a group leader at the Max Planck Institute for Chemical Ecology and a Junior Group Leader at the German Center for Integrated Biodiversity Research (iDiv). Her research program integrates molecular ecology, chemical signaling, and remote sensing to investigate genetic and functional diversity in plant systems. Research Interests: Her work spans molecular ecology, chemical ecology, and ecological genomics, with a focus on how spatial and temporal variation in plant traits influences ecological outcomes. She investigates plant volatiles, defense mechanisms, and the role of genetic diversity in species interactions. Her lab leverages advanced techniques such as imaging spectroscopy, metabolomics, and robotic sampling to study plant responses to herbivory and environmental stress. The most recent publications highlight a strong interdisciplinary trend, combining remote sensing , plant genomics , and chemical ecology . Key themes include the use of leaf spectroscopy to detect drought responses, the role of the circadian clock in plant defense, and the integration of metabolomics with biodiversity monitoring. Her research increasingly bridges field ecology with data science, particularly in trait imputation and satellite-based biodiversity mapping. Scientific Awards: Max Planck Society Otto Hahn Medal Fulbright Scholarship Advising and Grants: She actively mentors graduate students, as evidenced by her supervision of multiple master’s theses and doctoral dissertations. She leads scientific working groups such as the International Team "Genes from Space" and has secured research funding through her affiliations with MPICE, iDiv, and UZH. Her collaborative network is extensive, involving researchers across Europe and North America in large-scale ecological and genomic initiatives. Labs and Teams: Her research group combines molecular biology, chemical analysis, and remote sensing technologies. She collaborates closely with the Schaepman lab at UZH and participates in interdisciplinary teams focused on biodiversity monitoring, plant–insect interactions, and global change ecology.

Bradley C. Martinمشاهده پروفایل

استاد

• Opioid Use and Substance Use Disorders
• Pharmaceutical Policy Analyses
• Pharmacoepidemiologic and Pharmacoeconomic Research
• +۳ مورد دیگر

Dr. Bradley C. Martin is Professor and founding head of the Pharmaceutical Evaluation and Policy (PEP) Division at the University of Arkansas for Medical Sciences College of Pharmacy. With over two decades of experience, he teaches graduate courses in real-world evidence and cost-effectiveness modeling while advising 10 Ph.D. and 12 M.S. students. His research leverages large administrative datasets to advance pharmaceutical policy and opioid epidemic understanding. Dr. Martin's educational background includes: Pharm.D. from the University of Illinois Chicago (1989) Ph.D. in Pharmacy Care Administration from the University of Georgia (1993) His research spans opioid use disorders, pharmaceutical policy analyses, and pharmacoepidemiology using large administrative databases. He pioneered studies on acute-to-chronic opioid transition patterns that directly influenced U.S. policy, while developing cost-effectiveness models and risk adjustment methodologies for healthcare decision-making. His work integrates burden of illness studies with real-world evidence generation. Dr. Martin's scientific awards include: Arcansas HealthCare Heroes, Health Professional Hero of the Year (2019) Multiple ISPOR Distinguished Service Awards (2012-2016) Exceptional Reviewer honors from JMCP (2013, 2017, 2019) and Journal of Pharmacoepidemiology and Drug Safety (2012) ASHP Foundation Pharmacy Practice Research Award (2003) AFPE Fellow designation (2004) Arkansas College of Clinical Pharmacy Investigator Award (2016) He has advised 22 graduate students and secured research funding from NIH, AHRQ, VA, DOJ, research foundations, and pharmaceutical industry partnerships. Dr. Martin leads international initiatives through ISPOR, NPC, and AMCP to improve observational research standards and serves on ICER's Midwest Comparative Effectiveness Public Advisory Council for evidence-based clinical decision guidance.

• Cosmology
• Dark Matter
• Gravitational Lensing
• +۴ مورد دیگر

Joseph F. Hennawi is an Associate Professor in the Department of Physics at the University of California, Santa Barbara (UCSB), where he conducts research at the intersection of observational and theoretical cosmology using cutting-edge astronomical facilities. His research focuses on: Dark matter characterization through gravitational lensing Cosmic microwave background radiation analysis Spectroscopy of intergalactic and circumgalactic medium High-redshift quasar and galaxy evolution Rare astrophysical object identification via large-scale sky surveys He specializes in mining databases containing hundreds of millions of celestial objects to discover unique laboratories for testing fundamental physics, while conducting observations with the world's most powerful telescopes. Dr. Hennawi leads the ENIGMA research group at UCSB, dedicated to studying diffuse gas structures in cosmic environments using quasar absorption line techniques, with ongoing research into the intergalactic and circumgalactic medium.

Anna B. Halpernمشاهده پروفایل

دانشیار

• Hematology
• Oncology
• Myeloproliferative Neoplasms
• +۳ مورد دیگر

Dr. Anna B. Halpern is an Academic Associate Professor in the Division of Hematology and Oncology at the University of Washington and an Associate Professor in the Clinical Research Division at Fred Hutch Cancer Center in Seattle, Washington. She specializes in hematologic malignancies with a particular focus on myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Education: M.D. from Brown University Residency in Internal Medicine at University of Chicago Fellowship in Hematology-Oncology at UW/Fred Hutch Dr. Halpern's research focuses on improving outcomes for adults with hematologic malignancies through evidence-based, rational therapies tailored to individual patients. She designs and conducts clinical trials for patients with myeloid neoplasms and uses large databases to study systems-issues such as risk factors for treatment toxicities. As Principal Investigator, she leads multiple clinical trials for advanced myeloid neoplasms and has published extensively on treatment optimization in acute myeloid leukemia. Analysis of Dr. Halpern's recent publications reveals a consistent focus on acute myeloid leukemia treatment optimization, risk stratification, and comparative effectiveness research. Her work spans clinical trials, observational studies using large databases, and reviews of best practices in hematologic malignancy care, with particular attention to treatment settings (community vs. academic), performance status impact, and novel therapeutic approaches. Professional Activities: Principal Investigator for multiple clinical trials for advanced myeloid neoplasms Active contributor to hematology/oncology literature with over 50 publications Board certified in Internal Medicine, Hematology, and Medical Oncology Dr. Halpern maintains an active clinical practice at Fred Hutch Cancer Center - South Lake Union, where she sees patients with hematologic malignancies. She works to design personalized cancer care plans that balance patient and family needs with disease characteristics and the latest scientific advances and clinical trials.